TrialPanorama/TrialPanorama-database huggingface dataset:
Study 38174564 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TBX3 mRNA
Genes: TBX3
Study 38175251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38175448 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38175448 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study 38175595 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38175627 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38175669 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 38175669 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38175669 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38175669 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study 38175669 — Predictive Biomarker (PRD): Hormone receptor
Study 38176228 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 38176228 — Surrogate Endpoint (SUR): Blood pressure
Study 38176782 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 38177091 — Predictive Biomarker (PRD): EOMES mRNA
Genes: EOMES; TBR2
Study 38177116 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 38177128 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 38177178 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 38177853 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 38177853 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38177852 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 38177855 — Predictive Biomarker (PRD): SGCB mRNA
Genes: SGCB
Study 38178229 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 38178318 — Surrogate Endpoint (SUR): Blood pressure
Study 38178557 — Safety Biomarker (SAF): Interleukin 1
Study 38178557 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38180338 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 38180893 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38180983 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38181312 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38181784 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 38182406 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 38182406 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 38182687 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 38182687 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 38182687 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 38182687 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 38182687 — Predictive Biomarker (PRD): Hormone receptor
Study 38182785 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 38182785 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 38182920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38182920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38182920 — Safety Biomarker (SAF): IL-6 and IL-10
Study 38183047 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 38183067 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 38183067 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 38183081 — Surrogate Endpoint (SUR): Probing pocket depth
Study 38183273 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38184489 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 38184633 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 38184920 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 38185589 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 38185760 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 38188343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 38188343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38189180 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 38189492 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 38189999 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 38190001 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 38190226 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 38190242 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 38190578 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study 38190582 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 38190832 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 38191529 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38191529 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study 38191821 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study 38192435 — Surrogate Endpoint (SUR): Total kidney volume
Study 38194231 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study 38194247 — Predictive Biomarker (PRD): MIOS mRNA
Genes: MIOS
Study 38194272 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38194613 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 38194616 — Predictive Biomarker (PRD): Hormone receptor
Study 38194616 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 38194689 — Predictive Biomarker (PRD): RAC2 mRNA
Genes: RAC2
Study 38194692 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 38195172 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study 38195473 — Surrogate Endpoint (SUR): Blood pressure
Study 38195550 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 38195550 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38195600 — Surrogate Endpoint (SUR): Blood pressure
Study 38195732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38195732 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38195752 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 38195752 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38196118 — Surrogate Endpoint (SUR): Blood pressure
Study 38196617 — Predictive Biomarker (PRD): GMCL2 mRNA
Genes: GMCL2; GCL; GMCL1L; GMCL1P1
Study 38196650 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 38196756 — Safety Biomarker (SAF): Reactive oxygen species
Study 38196756 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38197815 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 38197816 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 38197863 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38198106 — Surrogate Endpoint (SUR): Plasma ammonia
Study 38199147 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 38199288 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 38199637 — Predictive Biomarker (PRD): BCAN mRNA
Genes: BCAN; BEHAB; CSPG7; UNQ2525/PRO6018
Study 38199751 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 38200233 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 38200320 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 38200320 — Surrogate Endpoint (SUR): Blood pressure
Study 38200621 — Surrogate Endpoint (SUR): Blood pressure
Study 38202070 — Predictive Biomarker (PRD): miR-21-5p
Genes: MIR21
Study 38202070 — Monitoring Biomarker (MOI): miR-24-3p
Study 38202070 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study 38203214 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 38203214 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 38203214 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 38203214 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 38203593 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 38203593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38204488 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38204866 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study 38206518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38206544 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 38207119 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 38211393 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38211606 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study 38212104 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 38212206 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 38212321 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38212823 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 38212823 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 38212850 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 38213401 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 38213637 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 38213637 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 38213637 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 38213637 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 38213637 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38214149 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 38214149 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 38214539 — Surrogate Endpoint (SUR): Blood pressure
Study 38214552 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 38215355 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 38215395 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 38215438 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 38215546 — Predictive Biomarker (PRD): NOX4 mRNA
Genes: NOX4; RENOX
Study 38216290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38216319 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 38216543 — Surrogate Endpoint (SUR): Blood pressure
Study 38216554 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 38216566 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 38216728 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 38216728 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 38216766 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 38216766 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 38216831 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 38216905 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study 38216971 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 38216985 — Surrogate Endpoint (SUR): Blood pressure
Study 38217361 — Predictive Biomarker (PRD): RTEL1 mRNA
Genes: RTEL1; C20orf41; KIAA1088; NHL
Study 38218924 — Surrogate Endpoint (SUR): Blood pressure
Study 38218979 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 38218979 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 38218979 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 38220413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38220592 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 38220592 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 38222312 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38222312 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 38224415 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 38224478 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38224478 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 38225549 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 38225551 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study 38225579 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 38225633 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 38226507 — Surrogate Endpoint (SUR): Blood pressure
Study 38226511 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38226511 — Surrogate Endpoint (SUR): Blood pressure
Study 38227033 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38227033 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 38227034 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 38227034 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 38227621 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 38227933 — Predictive Biomarker (PRD): CCR9 mRNA
Genes: CCR9; GPR28
Study 38227933 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 38228054 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 38228467 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 38229199 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 38231282 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 38231590 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38231777 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38232095 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38232336 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 38232336 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 38232682 — Surrogate Endpoint (SUR): Blood pressure
Study 38232682 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38232692 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38233075 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38233075 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 38233512 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38233570 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 38233575 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38233586 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38233586 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 38233608 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 38233810 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38233810 — Surrogate Endpoint (SUR): Pathological complete response
Study 38233816 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38233816 — Predictive Biomarker (PRD): ARHGEF5 mRNA
Genes: ARHGEF5; TIM
Study 38233908 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38235421 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38235421 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38235512 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38235741 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 38236249 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 38236249 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 38236575 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 38236581 — Predictive Biomarker (PRD): HOXB13 mRNA
Genes: HOXB13
Study 38236581 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 38236590 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38236590 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 38236602 — Surrogate Endpoint (SUR): Blood pressure
Study 38237075 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 38237077 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 38237620 — Surrogate Endpoint (SUR): Forced vital capacity
Study 38237675 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 38237796 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 38238055 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 38238060 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 38238620 — Predictive Biomarker (PRD): NUBP1 mRNA
Genes: NUBP1; NBP; NBP1
Study 38238616 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38238759 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 38238788 — Surrogate Endpoint (SUR): Forced vital capacity
Study 38240024 — Predictive Biomarker (PRD): SOCS1 mRNA
Genes: SOCS1; SSI1; TIP3
Study 38240024 — Predictive Biomarker (PRD): CD207 mRNA
Genes: CD207; CLEC4K
Study 38240024 — Predictive Biomarker (PRD): IL37 mRNA
Genes: IL37; FIL1Z; IL1F7; IL1H4; IL1RP1
Study 38240778 — Predictive Biomarker (PRD): MOXD1 mRNA
Genes: MOXD1; MOX; UNQ2493/PRO5780
Study 38240778 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 38240843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 38240916 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 38241058 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 38241058 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 38241059 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 38241354 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 38241661 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 38242333 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 38242575 — Monitoring Biomarker (MOI): Cell-free DNA
Study 38242717 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 38242720 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38242720 — Predictive Biomarker (PRD): Hormone receptor
Study 38243011 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 38243752 — Surrogate Endpoint (SUR): Bone mineral density
Study 38243906 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 38243998 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 38244708 — Surrogate Endpoint (SUR): Blood pressure
Study 38244708 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 38245818 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38246526 — Surrogate Endpoint (SUR): Blood pressure
Study 38247010 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38247384 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 38249336 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 38249987 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 38250270 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 38250270 — Safety Biomarker (SAF): BDNF
Study 38250275 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 38251524 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38251563 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38251576 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38251576 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38251576 — Predictive Biomarker (PRD): FCGR2B
Genes: CD32; CD32B; FcgammaRIIb; FcGRIIB
Study 38251590 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 38251590 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38252211 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38252211 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 38252907 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38252910 — Monitoring Biomarker (MOI): Cell-free DNA
Study 38252910 — Surrogate Endpoint (SUR): Serum creatinine
Study 38253245 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 38253701 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1